Form 4 for BDX Becton Dickinson
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-26 · accession 0001062993-22-022937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-29 | 2022-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $0.00 | +1,816 | 5,147 | +55% | $0 |
| DM | 2022-11-29 | 2022-11-26 | BDX | Hickey David | EVP, Pres, Life Sciences | A - Grant | $0.00 | +12.1K | 12.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-26 | A | A | 1,816 | $0.00 | 5,147 | D | — | — | (F1) Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
| 2 | Derivative | Stock Appreciation Rights | 2022-11-26 | A | A | 10,975 | $0.00 | 10,975 | D | $238.06 · 2023-11-26 to 2032-11-26 | 10,975 Common Stock | (F2) The stock appreciation rights vest in four annual installments beginning November 26, 2023. |
| 3 | Derivative | Rights to Common Stock Under Deferred Compensation Plan | 2022-11-26 | A | A | 1,125 | $0.00 | 12,100 | D | $238.06 · — to — | 1,125 Common Stock | (F3) The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person |